Product NDC: | 24208-545 |
Proprietary Name: | Levobunolol Hydrochloride |
Non Proprietary Name: | Levobunolol Hydrochloride |
Active Ingredient(s): | 2.5 mg/mL & nbsp; Levobunolol Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-545 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074307 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940304 |
Package NDC: | 24208-545-10 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (24208-545-10) > 10 mL in 1 BOTTLE, DROPPER |
NDC Code | 24208-545-10 |
Proprietary Name | Levobunolol Hydrochloride |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (24208-545-10) > 10 mL in 1 BOTTLE, DROPPER |
Product NDC | 24208-545 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levobunolol Hydrochloride |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 19940304 |
Marketing Category Name | ANDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | LEVOBUNOLOL HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |